Zacks.com on MSN5h
Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Moderna (MRNA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...
MRNA, PFE, BNTX: Pharma Stocks Fall as RFK Jr. Set to Become U.S. Health Secretary
Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...
Hosted on MSN1d
Do Wall Street Analysts Like Moderna Stock?
Valued at $13.1 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...
Why MRNA Stock Is Retreating
The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...
Moderna: The Good News Isn't Enough
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
Moderna Stock Is Sliding Wednesday: Here's Why
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Yahoo Finance9d
Why MRNA Stock Is Retreating
The analyst cut her price target on MRNA to $51 from $99 ... which MRNA is developing in partnership with Merck (MRK), to lift MRNA stock this year. Ellison's Statement on Potential Cancer ...